Colorcon expands functional film coatings through the CR Alliance with DuPont

The Aquacoat product line provides modified release drug profiles with the added benefit of global regulatory acceptance.

The Aquacoat product line includes Aquacoat ECD for sustained release and Aquacoat CPD for enteric coating applications. These aqueous functional coatings are designed for use in both pharmaceutical and nutritional solid dose applications. They provide modified release drug profiles with the added benefit of global regulatory acceptance.

Jayesh Parmar, General Manager at Colorcon says: “The addition of these products further augments the Alliance’s ability to fulfill the needs of the pharmaceutical industry and provide unique solutions to deliver efficiency, cost savings, and dependable performance.”

Martti Hedman, CEO adds: “Colorcon and DuPont, together through the Alliance, continue to deliver increased value and innovative solutions for our pharmaceutical customers. The addition of new products strengthens the global relationship and enhances our market leadership position.”

“We want to ensure that our customers receive the highest possible levels of service,” adds Pauel Fokin, Global Commercial Director, Pharma Solutions, DuPont. “This move provides a one-stop shop for their controlled release application needs and demonstrates our continued commitment to the Controlled Release Alliance with Colorcon.”

Since 2007, the Alliance has served the needs of the pharmaceutical industry, providing customized solutions, products and support services for pharmaceutical product development. The addition of the Aquacoat products into the Alliance portfolio demonstrates the continued strong relationship between Colorcon and DuPont and enhances the range of solutions provided to meet industry needs.